Glapp is a GLP-1 tracker with a free core app: shots, daily check-ins, medication-level curves, supply tracking and AI answers from research, with an optional paid tier. PepMe is built for whole protocols, peptides and hormones as well as GLP-1s, with bloodwork and sharing with your clinic.
Checked against Glapp's own App Store listing, website and privacy policy on October 20, 2026.
| PepMe | Glapp | |
|---|---|---|
| Dose log and reminders | Yes, by push or email, with a missed-dose follow-up | Yes |
| Peptides and hormones, not only GLP-1s | Yes: GLP-1s, peptides such as BPC-157, and TRT | Built for GLP-1 medications |
| Injection sites | Yes, body map and suggested next site | Yes, logged with each shot |
| Supply tracking | Yes, counted down, with a reorder reminder | Yes: vials, pens, concentration, beyond-use dates; low-supply prediction in Max |
| Bloodwork | Yes, against ranges and over time | Not listed |
| Share with your clinic | Yes, you choose what they see; every look logged | Not listed |
| Daily check-in and side effects | Yes, journal and check-in reminders | Yes, including hunger and food noise |
| Medication-level curve | No | Yes |
| AI answers | No | Yes, from clinical trials and research |
| Weekly report | Yes, included | Yes, in Glapp Max |
| Platforms | iPhone; Android in beta; web | iPhone, Android and web |
| Price | 30 days free, then $4.99/month or $29.99/year | Core app free; Glapp Max $9.99/month or $39.99/year |
| Analytics and advertising | No ad trackers in the app | Amplitude product analytics; no third-party targeted advertising, per its privacy policy |
What we say about Glapp comes from its own published pages, checked October 20, 2026. Things change; if something here is out of date, tell us at [email protected] and we'll fix it.
Glapp is a trademark of its owner. PepMe is not affiliated with it. Neither app gives medical advice.